Yann Mazabraud

Corporate Officer/Principal bei RHYTHM PHARMACEUTICALS, INC.

Vermögen: 1 Mio $ am 31.05.2024

51 Jahre

Health Technology

Consumer Services

Aktive Positionen von Yann Mazabraud

Unternehmen	Position	Beginn	Ende
RHYTHM PHARMACEUTICALS, INC.	Corporate Officer/Principal	05.10.2020	-

Unternehmen	Position	Beginn	Ende
TREVI THERAPEUTICS, INC.	Corporate Officer/Principal	01.11.2017	03.10.2020
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01.01.2016	01.10.2017
Genzyme Therapeutics Ltd. Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom.	Corporate Officer/Principal	-	-

Groupe de Sup de Co La Rochelle

Graduate Degree

International

Operativ

Corporate Officer/Principal	4
Graduate Degree	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
TREVI THERAPEUTICS, INC.	Health Technology
RHYTHM PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	2
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology
Genzyme Therapeutics Ltd. Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom.	Health Technology